Wells Fargo
NVLN

Wells Fargo’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Wells Fargo’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-20
Closed – – 7139
2019
Q3 		$0 Hold
20
– – ﹤0.01% 7042
2019
Q2 		$0 Hold
20
– – ﹤0.01% 6907
2019
Q1 		$0 Hold
20
– – ﹤0.01% 6794
2018
Q4 		$0 Sell
20
-309
-94% -$349 ﹤0.01% 6805
2018
Q3 		$1K Hold
329
– – ﹤0.01% 6350
2018
Q2 		$1K Sell
329
-8,713
-96% -$35K ﹤0.01% 6285
2018
Q1 		$31K Buy
9,042
+39
+0.4% +$165 ﹤0.01% 5712
2017
Q4 		$28K Buy
9,003
+7,640
+561% +$36.7K ﹤0.01% 5709
2017
Q3 		$9K Buy
1,363
+1,034
+314% +$8.29K ﹤0.01% 5909
2017
Q2 		$3K Buy
329
+20
+6% +$193 ﹤0.01% 6022
2017
Q1 		$3K Hold
309
– – ﹤0.01% 6135
2016
Q4 		$3K Buy
+309
New +$2.74K ﹤0.01% 6062

Other funds holding NVLN

SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
DMK
David M. Knott $264M AUM 59.23% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return